why choose us

First received: June 05, 2023

Clinical Trial: Study of Subcutaneously Administered ENT-03 for the Treatment of Obesity and Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Obesity

Study Type: INTERVENTIONAL


Official Title: A First in Human, Single Center, Single Dose, Randomized, Placebo-controlled, Dose, Escalating Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administe

Brief Summary: Single center, single-dose, randomized, placebo-controlled, dose-escalating study to evaluate, safety, tolerability, pharmacokinetics, and pharmacodynamics of escalating doses of ENT-03S in obese but otherwise healthy subjects and in subjects with obesity and Type 2 diabetes.

Read more